Prof. Dr. Raja Atreya

Professur für Translationale Immunforschung bei chronisch entzündlichen Darmerkrankungen

Targeting of the Tec Kinase ITK Drives Resolution of T Cell–Mediated Colitis and Emerges as Potential Therapeutic Option in Ulcerative Colitis (2021) Lechner-Grimm K, Mott S, Al-Saifi R, Knipfer L, Wirtz S, Atreya R, Vieth M, et al. Journal article A Systematic Review on Infliximab Biosimilar SB2: From Pre-Clinical Data to Real-World Evidence (2021) Macaluso FS, Cummings JF, Atreya R, Choi J, Orlando A Journal article, Review article Expression of inflammatory mediators in biofilm samples and clinical association in inflammatory bowel disease patients—a preliminary study (2021) Buchbender M, Fehlhofer JP, Proff P, Möst T, Ries J, Hannig M, Neurath M, et al. Journal article Positionspapier zur Befunderstellung endoskopischer Untersuchungen bei Patienten mit chronisch-entzündlichen Darmerkrankungen (2021) Schmidt C, Bachmann O, Baumgart DC, Goetz M, Drvarov O, Kucharzik TF, Kuehbacher T, et al. Journal article SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases (2021) Simon D, Tascilar K, Fagni F, Krönke G, Kleyer A, Meder C, Meder C, et al. Journal article Current Endoscopic Resection Techniques for Gastrointestinal Lesions: Endoscopic Mucosal Resection, Submucosal Dissection, and Full-Thickness Resection (2021) Hoffman A, Atreya R, Rath T, Neurath M Journal article, Review article Molecular Imaging and its Applications in Selected GI Diseases (2021) Rath T, Neurath M, Atreya R Journal article, Review article Location is important: differentiation between ileal and colonic Crohn’s disease (2021) Atreya R, Siegmund B Journal article, Review article Is histological healing a feasible endpoint in ulcerative colitis? (2021) Rath T, Atreya R, Neurath M Journal article, Review article Long-term effectiveness, safety and immunogenicity of the biosimilar SB2 in inflammatory bowel disease patients after switching from originator infliximab (2021) Fischer S, Cohnen S, Klenske E, Schmitt H, Vitali F, Hirschmann S, Ramming A, et al. Journal article